Statistics for Utilising FGF2, IGF2 and FSH in serum-free protocol for long-term in vitro cultivation of primary human granulosa cells
Total visits
views | |
---|---|
Utilising FGF2, IGF2 and FSH in serum-free protocol for long-term in vitro cultivation of primary human granulosa cells | 274 |
Total visits per month
views | |
---|---|
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 1 |
July 2024 | 0 |
August 2024 | 0 |
File Visits
views | |
---|---|
1s2_0_S0303720720301167_mmc1.pdf | 132 |
1s2_0_S0303720720301167.pdf | 70 |
1s2_0_S0303720720301167_mmc2.docx | 25 |
Top country views
views | |
---|---|
United States | 147 |
China | 37 |
Germany | 24 |
Netherlands | 12 |
Russia | 9 |
Estonia | 6 |
Sweden | 6 |
Ukraine | 5 |
Ireland | 4 |
Vietnam | 4 |
Belgium | 2 |
Australia | 1 |
Bulgaria | 1 |
Finland | 1 |
France | 1 |
Iran | 1 |
Kyrgyzstan | 1 |
South Korea | 1 |
Top city views
views | |
---|---|
Louisville | 24 |
Chandler | 21 |
Ashburn | 20 |
San Mateo | 18 |
San Ramon | 13 |
Cambridge | 8 |
Fairfield | 8 |
Foshan | 8 |
Stockholm | 6 |
Ann Arbor | 5 |
Des Moines | 5 |
Jacksonville | 5 |
Beijing | 4 |
Hanoi | 4 |
Jinan | 4 |
Dublin | 3 |
Redwood City | 3 |
Wuhan | 3 |
Augusta | 2 |
Brussels | 2 |
Chongqing | 2 |
Falls Church | 2 |
Nanjing | 2 |
Taganrog | 2 |
Tallinn | 2 |
Belgorod | 1 |
Blagoveshchensk | 1 |
Borisoglebsk | 1 |
Boston | 1 |
Chengdu | 1 |
Engelhard | 1 |
Farmingdale | 1 |
Guangzhou | 1 |
Helsinki | 1 |
Phoenix | 1 |
Saint Petersburg | 1 |
San Jose | 1 |
Saransk | 1 |
Seattle | 1 |
Seoul | 1 |
Shanghai | 1 |
Shenzhen | 1 |
Sofia | 1 |
Zhitomir | 1 |